Growth N. V. Biotech, 10% Owner at Black Diamond Therapeutics, Inc. (BDTX), bought 199,602 shares at $2.25 ($449K) on 2022-10-31, disclosed to the SEC on 2022-11-02.
Open-market purchase of $449k BDTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.25 | 99,801 | $225K | 50.0% |
| 2 | $2.25 | 99,801 | $225K | 50.0% |
| Total | $2.25 avg | 199,602 | $449K | 100% |
| Filing → |
| BDTX | BUY | 2023-06-29 | $9.6M | — | Filing → |
| EPIX | BUY | 2022-10-28 | $8.2M | — | Filing → |
| EPIX | BUY | 2022-07-18 | $3.5M | — | Filing → |